• Users Online: 371
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
RESEARCH ARTICLE
Year : 2014  |  Volume : 3  |  Issue : 1  |  Page : 90-98

Production and secretion of TNF related apoptosis inducing ligand (TRAIL/Apo2L) in the Escherichia coli periplasm using PhoA signal peptide


1 Pharmaceutical Biotechnology Department, School of Pharmacy, Shahid Beheshti University of Medical Sciences; Student's Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences; Biotechnology Department, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Pharmaceutical Biotechnology Department, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Correspondence Address:
Bahram Kazemi
Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences; Biotechnology Department, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran
Iran
Nastaran Nafissi-Varcheh
Pharmaceutical Biotechnology Department, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran
Iran
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

The ability of TNF related apoptosis inducing ligand/Apo2 ligand (TRAIL/Apo2L) in order to selectively induce apoptosis in tumor cells but not normal cells makes it an attractive target for development of new cancer therapy. Although TRAIL/Apo2L has been produced in several hosts, E. coli is one of the best expression systems among them due to its safety, simplicity, low cultivation cost, and known genetic properties. However, cytoplasmic expression of TRAIL/Apo2L in E. coli may be concomitant with some problems such as protease-induced degradation, protein misfolding, diminution in the biological activity and complexity of downstream processing. Therefore, the aim of this study was the development of an expression system to produce and secrete recombinant TRAIL/Apo2L into the E. coli periplasmic space. DNA encoding Alkaline Phosphatase (PhoA) signal peptide was added to the TRAIL/Apo2L cDNA using overlapping extension PCR procedure. PhoA-TRAIL construct was subsequently cloned in pET-22b expression plasmid and correct cloning was confirmed by PCR and sequencing. TRAIL/Apo2L expression was induced in E. coli BL21 (DE3) and then its periplasmic fraction was isolated through osmotic shock. SDS-PAGE analysis showed that recombinant TRAIL/Apo2L was successfully secreted into E. coli periplasm. The periplasmic TRAIL/Apo2L was identified by western blotting analysis. Finally, the biological activity of the purified periplasmic TRAIL/Apo2L was assessed by MTT assay to evaluate its growth inhibitory effect against the HeLa cell line. In conclusion, the results demonstrate that our TRAIL/Apo2L expression system could be an interesting alternative to reduce problems arose from the cytoplasmic production of TRAIL/Apo2L.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed297    
    Printed28    
    Emailed0    
    PDF Downloaded43    
    Comments [Add]    

Recommend this journal